Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
LUNG Pulmonx	$1.77 +6.0%	$2.41	$1.47 ▼ $9.37	$72.12M	0.43	455,345 shs	831,971 shs
NRXS NeurAxis	$2.45 -3.5%	$2.52	$1.33 ▼ $6.20	$24.16M	3.1	650,604 shs	39,410 shs
SPAI Safe Pro Group	$6.11 -10.0%	$3.48	$1.47 ▼ $7.05	$98.80M	N/A	162,445 shs	579,109 shs
TELA TELA Bio	$1.80 -1.6%	$1.85	$0.86 ▼ $3.26	$71.31M	0.93	174,638 shs	108,065 shs

7 Energy Stocks to Buy and Hold Forever

With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
LUNG Pulmonx	-1.18%	+4.37%	-50.00%	-45.95%	-77.76%
NRXS NeurAxis	+2.83%	+2.42%	-8.30%	-14.19%	-17.53%
SPAI Safe Pro Group	+19.33%	+67.24%	+78.68%	+149.63%	+678,999,900.00%
TELA TELA Bio	+3.39%	+7.65%	-4.69%	+23.65%	-38.18%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
LUNG Pulmonx	4.2151 of 5 stars	4.3	4.0	2.9	3.3	1.3
NRXS NeurAxis	2.4589 of 5 stars	3.5	3.0	1.1	3.3	0.0
SPAI Safe Pro Group	0.9192 of 5 stars	2.0	0.0	3.0	1.7	0.0
TELA TELA Bio	3.1102 of 5 stars	3.3	4.0	3.6	1.7	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
LUNG Pulmonx	2.56	Moderate Buy	$7.66	339.21% Upside
NRXS NeurAxis	3.00	Buy	$7.00	185.13% Upside
SPAI Safe Pro Group	4.00	Strong Buy	$8.00	31.04% Upside
TELA TELA Bio	2.50	Moderate Buy	$4.50	138.10% Upside

Current Analyst Ratings Breakdown

Latest NRXS, TELA, SPAI, and LUNG Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
8/1/2025	LUNG Pulmonx	Wells Fargo & Company Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Equal Weight ➝ Equal Weight	$6.00 ➝ $3.00
7/31/2025	LUNG Pulmonx	Lake Street Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$12.00 ➝ $8.00
7/31/2025	LUNG Pulmonx	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$16.00 ➝ $5.00
7/31/2025	LUNG Pulmonx	D. Boral Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Buy ➝ Buy	$17.00 ➝ $16.00
7/31/2025	LUNG Pulmonx	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Overweight ➝ Neutral	$9.00 ➝ $2.50
7/17/2025	SPAI Safe Pro Group	Litchfield Hills Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$8.00
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Buy
6/16/2025	NRXS NeurAxis	Craig Hallum Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Strong-Buy	$7.00

(Data available from 8/26/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
LUNG Pulmonx	$90.55M	0.79	N/A	N/A	$2.17 per share	0.80
NRXS NeurAxis	$3.22M	7.52	N/A	N/A	($0.27) per share	-9.09
SPAI Safe Pro Group	$2.17M	45.49	N/A	N/A	$0.28 per share	21.80
TELA TELA Bio	$75.32M	0.99	N/A	N/A	$0.72 per share	2.63

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
LUNG Pulmonx	-$56.39M	-$1.43	N/A	N/A	N/A	-62.88%	-69.76%	-36.26%	10/29/2025 (Estimated)
NRXS NeurAxis	-$14.63M	-$0.99	N/A	∞	N/A	-492.76%	N/A	-641.25%	N/A
SPAI Safe Pro Group	-$7.43M	-$0.80	N/A	∞	N/A	-731.46%	-328.85%	-248.09%	9/25/2025 (Estimated)
TELA TELA Bio	-$37.84M	-$1.12	N/A	N/A	N/A	-54.12%	-329.48%	-57.34%	11/6/2025 (Estimated)

Latest NRXS, TELA, SPAI, and LUNG Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/14/2025	Q2 2025	SPAI Safe Pro Group	N/A	-$0.13	N/A	-$0.13	N/A	$0.09 million
8/11/2025	Q2 2025	TELA TELA Bio	-$0.18	-$0.22	-$0.04	-$0.22	$20.67 million	$20.20 million
7/30/2025	Q2 2025	LUNG Pulmonx	-$0.40	-$0.38	+$0.02	-$0.38	$23.46 million	$23.86 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
LUNG Pulmonx	N/A	N/A	N/A	N/A	N/A
NRXS NeurAxis	N/A	N/A	N/A	N/A	N/A
SPAI Safe Pro Group	N/A	N/A	N/A	N/A	N/A
TELA TELA Bio	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
LUNG Pulmonx	0.54	5.35	4.63
NRXS NeurAxis	N/A	0.24	0.23
SPAI Safe Pro Group	0.06	1.64	1.27
TELA TELA Bio	4.14	3.19	2.59

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
LUNG Pulmonx	91.04%
NRXS NeurAxis	11.77%
SPAI Safe Pro Group	N/A
TELA TELA Bio	94.35%

Insider Ownership

Company	Insider Ownership
LUNG Pulmonx	6.80%
NRXS NeurAxis	26.40%
SPAI Safe Pro Group	54.80%
TELA TELA Bio	4.70%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
LUNG Pulmonx	250	40.75 million	37.98 million	Optionable
NRXS NeurAxis	19	9.86 million	6.09 million	Not Optionable
SPAI Safe Pro Group	11	16.17 million	7.31 million	N/A
TELA TELA Bio	120	39.62 million	37.75 million	Optionable

NRXS, TELA, SPAI, and LUNG Headlines

Recent News About These Companies

Stonepine Capital Management LLC Has $2.51 Million Stake in TELA Bio, Inc. $TELA

August 26 at 7:38 AM | marketbeat.com

TELA Bio (NASDAQ:TELA) Shares Down 2.9% - Here's What Happened

August 23 at 3:18 AM | marketbeat.com

Aroa Biosurgery Reports Strong Growth and Expands Product Range Amid Market Challenges

August 20, 2025 | msn.com

Tela Bio reports Q2 EPS (22c), consensus (19c)

August 13, 2025 | msn.com

TELA Bio (NASDAQ:TELA) Issues Earnings Results

August 12, 2025 | marketbeat.com

Tela Bio backs FY25 revenue view $85M-$88M, consensus $86.05M

August 12, 2025 | msn.com

Tela Bio reiterates $85M–$88M 2025 revenue target as international expansion accelerates

August 12, 2025 | msn.com

TELA Bio, Inc. (TELA) Reports Q2 Loss, Lags Revenue Estimates

August 11, 2025 | zacks.com

TELA Bio, Inc. (TELA) Q2 2025 Earnings Call Transcript

August 11, 2025 | seekingalpha.com

TELA Bio Reports Second Quarter 2025 Financial Results

August 11, 2025 | globenewswire.com

TELA Bio Inc (TELA) Q2 2025 Earnings Report Preview: What To Expect

August 10, 2025 | finance.yahoo.com

TELA Bio Awards Inducement Equity Grants to New Employees

August 10, 2025 | msn.com

TELA Bio Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

August 8, 2025 | globenewswire.com

TELA Bio (TELA) Expected to Announce Quarterly Earnings on Monday

August 5, 2025 | marketbeat.com

TELA Bio (NASDAQ:TELA) Trading 4.2% Higher - Time to Buy?

July 30, 2025 | marketbeat.com

TELA Bio to Participate in the Canaccord Genuity 45th Annual Growth Conference

July 23, 2025 | globenewswire.com

TELA Bio to Announce Second Quarter 2025 Financial Results

July 21, 2025 | globenewswire.com

TELA Bio, Inc. (TELA) Latest Stock News & Headlines - Yahoo Finance

July 19, 2025 | finance.yahoo.com

Breakeven On The Horizon For TELA Bio, Inc. (NASDAQ:TELA)

July 3, 2025 | finance.yahoo.com

TELA Bio Welcomes Jim Hagen with Strategic Equity Grant

June 9, 2025 | msn.com

TELA Bio, Inc.: TELA Bio Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

June 7, 2025 | finanznachrichten.de

New MarketBeat Followers Over Time

Media Sentiment Over Time

NRXS, TELA, SPAI, and LUNG Company Descriptions

Pulmonx NASDAQ:LUNG

$1.77 +0.10 (+5.99%)

Closing price 04:00 PM Eastern

Extended Trading

$1.78 +0.00 (+0.28%)

As of 05:09 PM Eastern

Pulmonx Corporation, a commercial-stage medical technology company, provides minimally invasive devices for the treatment of chronic obstructive pulmonary diseases. The company offers Zephyr Endobronchial Valve, a solution for the treatment of patients with hyperinflation associated with severe emphysema; and Chartis Pulmonary Assessment System, a balloon catheter and console system with flow and pressure sensors that are used to assess the presence of collateral ventilation. It also offers StratX Lung Analysis Platform, a cloud-based quantitative computed tomography analysis service that offers information on emphysema destruction, fissure completeness, and lobar volume to help identify target lobes for the treatment with Zephyr Valves. The company serves emphysema patients in the United States, Europe, the Middle East, Africa, the Asia-Pacific, and internationally. The company was formerly known as Pulmonx and changed its name to Pulmonx Corporation in December 2013. Pulmonx Corporation was incorporated in 1995 and is headquartered in Redwood City, California.

NeurAxis NASDAQ:NRXS

$2.45 -0.09 (-3.54%)

Closing price 04:00 PM Eastern

Extended Trading

$2.46 +0.00 (+0.20%)

As of 04:15 PM Eastern

NeurAxis, Inc., a medical technology company, focuses on developing neuromodulation therapies to address chronic and debilitating conditions in children and adults in the United States. It offers IB-Stim, a percutaneous electrical nerve field stimulation system intended to be used in patients 11-18 years of age with functional abdominal pain associated with irritable bowel syndrome. The company sells its products to healthcare companies, including hospitals and clinics. The company was formerly known as Innovative Health Solutions, Inc. and changed its name to NeurAxis, Inc. in March 2022. The company was founded in 2011 and is headquartered in Carmel, Indiana.

Safe Pro Group NASDAQ:SPAI

$6.11 -0.68 (-10.01%)

Closing price 04:00 PM Eastern

Extended Trading

$6.13 +0.02 (+0.39%)

As of 05:24 PM Eastern

Safe Pro Group, Inc. engages in the provision and acquisition of security and protection products. Its products include Artificial Intelligence (AI) and Machine Learning (ML) software technology and photogrammetry analysis tools, bullet and blast resistant personal protection equipment, and aerial managed services and mission-critical uncrewed solutions. The firm operates through the following segments: Safe-PRO USA, Airborne Response, and Safe Pro AI. The company was founded by Daniyel Erdberg on December 15, 2021 and is headquartered in Aventura, FL.

TELA Bio NASDAQ:TELA

$1.80 -0.03 (-1.64%)

Closing price 04:00 PM Eastern

Extended Trading

$1.81 +0.01 (+0.56%)

As of 05:26 PM Eastern

TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time